Search for: All records

The co-occurrence of uranyl and arsenate in contaminated water caused by natural processes and mining is a concern for impacted communities, including in Native American lands in the U.S. Southwest. We investigated the simultaneous removal of aqueous uranyl and arsenate after the reaction with limestone and precipitated hydroxyapatite (HAp, Ca10(PO4)6(OH)2). In benchtop experiments with an initial pH of 3.0 and initial concentrations of 1 mM U and As, uranyl and arsenate coprecipitated in the presence of 1 g L−1 limestone. However, related experiments initiated under circumneutral pH conditions showed that uranyl and arsenate remained soluble. Upon addition of 1 mM PO43− and 3 mM Ca2+ in solution (initial concentration of 0.05 mM U and As) resulted in the rapid removal of over 97% of U via Ca−U−P precipitation. In experiments with 2 mM PO4 3− and 10 mM Ca2+ at pH rising from 7.0 to 11.0, aqueous concentrations of As decreased (between 30 and 98%) circa pH 9. HAp precipitation in solids was confirmed by powder X-ray diffraction and scanning electron microscopy/energy dispersive X-ray. Electron microprobe analysis indicated U was coprecipitated with Ca and P, while As was mainly immobilized through HAp adsorption. The results indicate that natural materials, such as HAp and limestone, can effectively remove uranyl and arsenate mixtures. 

The leitmotifs of magnetic resonance imaging (MRI) contrast agent-induced complications range from acute kidney injury, symptoms associated with gadolinium exposure (SAGE)/gadolinium deposition disease, potentially fatal gadolinium encephalopathy, and irreversible systemic fibrosis. Gadolinium is the active ingredient of these contrast agents, a non-physiologic lanthanide metal. The mechanisms of MRI contrast agent-induced diseases are unknown. Mice were treated with a MRI contrast agent. Human kidney tissues from contrast-naïve and MRI contrast agent-treated patients were obtained and analyzed. Kidneys (human and mouse) were assessed with transmission electron microscopy and scanning transmission electron microscopy with X-ray energy-dispersive spectroscopy. MRI contrast agent treatment resulted in unilamellar vesicles and mitochondriopathy in renal epithelium. Electron-dense intracellular precipitates and the outer rim of lipid droplets were rich in gadolinium and phosphorus. We conclude that MRI contrast agents are not physiologically inert. The long-term safety of these synthetic metal–ligand complexes, especially with repeated use, should be studied further.

 

The objective of this study was to investigate the application of manganese oxide [MnO x(s) ] and granular activated carbon (GAC) media for the removal of caffeine and acetaminophen from water. Organic contaminants of emerging concern represent a developing issue due to their effects on human health and the environment. Manganese oxides are effective for water treatment because of their ability to mediate adsorption and oxidation–reduction reactions for many organic and inorganic constituents. Laboratory scale column experiments were performed using different combinations of commercial MnO x(s) and GAC for assessing the removal of caffeine and acetaminophen, and the subsequent release of soluble Mn due to the reductive dissolution of MnO x(s) . The removal of acetaminophen was detected for all media combinations investigated. However, the removal of caffeine by adsorption only occurred in columns containing GAC media. There was no removal of caffeine in columns containing only MnO x(s) media. Manganese release occurred in columns containing MnO x(s) media, but concentrations were below the secondary drinking water standard of 50 μg L −1 set by the US Environmental Protection Agency. Soluble Mn released from a first process by MnO x(s) media column was removed through adsorption into the GAC media used in a second process. The results of this investigation are relevant for implementation of MnO x(s) and GAC media combinations as an effective treatment process to remove organic contaminants from water.